Adverum Biotechnologies Announces Proposed Public Offering of Common Stock

World News: . []

MENLO PARK Calif Feb 07 2018 GLOBE NEWSWIRE -- Adverum Biotechnologies Inc NasdaqADVM a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, today announced that it has commenced an un derwrit...

More news and information about Adverum Biotechnologies, Inc.

Published By:

Globe Newswire: 21:01 GMT Wednesday 7th February 2018

Published: .

Search for other references to "adverum" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us